Sign in Subscribe
Featured

CF Benchmarks Recap - Issue 20

A more pressing question than ‘where next for BTC’s price?’ was whether the OSC’s resoluteness would encourage the SEC off the fence

Ken Odeluga

• 4 min read
CF Benchmarks Recap - Issue 20

Crypto takes giant leap forward with Evolve’s Bitcoin ETF

BlackRock dabbles, NYDIG files, MicroStrategy buys more

Bitcoin points upwards from $56k into the weekend

45634233761_3c688fbd41_c
‘EBIT’ caps $100k half-way point
For the umpteenth week, keeping up with crypto ‘capitulation’ news flow has been a challenge in itself, whilst the trading atmosphere remained heady: Bitcoin was around 10% higher on Friday alone by late North American trading. Meanwhile, the apparent return of animal spirits to conventional asset classes coincided with the continuing catalytic convergence of ever more weighty institutions into the digital assets space, creating a virtuous circle of rising prices and increasingly influential participants. With our regulated Bitcoin Real Time Index breaking beyond the week’s $50k milestone into the $56k handle at the time of writing (latest record: $56,336.65, timestamp: 21.13.05 UTC) the natural question was where and when the expansive run might end. There are no answers to speculative questions here, unfortunately. In principle though, such concerns were superseded by one of the week’s most promising inflection points: the Ontario Securities Commission granting regulatory approval to only the second Bitcoin ETF ever - days after giving the OK to the first. What’s more, in a rapid evolution relative to the first BTC product to which the term ‘ETF’ is ascribable in the strictest legal sense, Evolve Funds Group Inc.’s Bitcoin ETF (TSX ticker: EBIT) is the first with a portfolio and NAV calculated by a regulated benchmark, The Bitcoin Reference Rate (BRR). Evolution for the asset class indeed. As such, a more pressing question than ‘where next for BTC’s price?’ was whether the OSC’s resoluteness would encourage the SEC off the fence.

Evolve Bitcoin ETF (EBIT) – Top 5 facts

  1. It invests directly in Bitcoin, not BTC derivatives.
  2. Its portfolio and daily NAV are based on the CME CF Bitcoin Reference Rate, the benchmark devised and administered by EU-authorised, UK FCA-regulated Benchmark Administrator, CF Benchmarks.
  3. Unhedged (EBIT) and U.S. dollar-hedged (EBIT.U) units are available.
  4. In line with its goal of direct Bitcoin access, EBIT’s Bitcoin investments are generally passive or in response to subscriptions. Disposals mostly fund expenses and redemptions.
  5. In Canada, EBIT is eligible for Tax Free Savings Accounts and Registered Retirement Savings Plans. Direct Bitcoin holdings are not.

Capitulation & Expansion: BLK, NYDIG, BITW, MSTR
Following BlackRock’s recently gained facility to trade, regulated cash-settled BTC futures (there’s only one such contract), it this week signalled it’s started to dabble. Bitwise outpaced heavyweight rivals to the launch of the first-ever DeFi index fund. It’s for accredited investors only. NYDIG, custodian of at least $1bn in BTC, threw its ETF hat into the ring with the latest application to the SEC. MicroStrategy isn’t done buying Bitcoin. It said the around $1bn raised from this week’s convertible notes sale would be allocated to a purchase of that size.

The Returns: EOSUSD_RR also rises
The current crypto rally continues to lift many (if not all) boats, including EOS. An 89% return of the CF EOS-Dollar Settlement Price follows an 107% surge from 27th January’s low of $2.498 to Friday’s close at $5.172. The alternative smart contract protocol has largely been side-lined by DeFi mania.
Screenshot-2021-02-19-at-23.44.45

Featured benchmarks: CME CF Bitcoin Reference Rate

BRR powered Bitcoin ETF from Evolve Funds wins Regulatory Approval in Canada

The Net Asset Value of the fund will be calculated using the BRR and hence the value at which the shares in the fund will be created and redeemed by investors will be at that day's BRR value.

Evolve Funds Group Inc. has received regulatory approval from the Ontario Securities Commission ("OSC") to launch the Bitcoin ETF, one of the world's first open-ended bitcoin ETFs.

The Bitcoin ETF will be known by the ticker “EBIT”. The ETF will launch on the Toronto Stock Exchange (“TSX”) subject to TSX approval. EBIT is designed to provide investors with exposure to the world’s leading cryptocurrency, bitcoin, by investing directly in bitcoin and tracking the CME CF Bitcoin Reference Rate ("BRR") from CF Benchmarks. The Net Asset Value of the fund will be calculated using the BRR and hence the value at which shares in the fund are to be created and redeemed will be the BRR value on that day.

“The Bitcoin ETF is exciting news for investors,” said Raj Lala, President and CEO of Evolve ETFs. “Investors will be able to trade bitcoin on a regulated stock exchange. It will be as simple as buying shares through their bank or brokerage. Unlike the technical challenges of investing in bitcoin, units of EBIT will be safely transacted via a familiar brokerage investing platform. EBIT will provide daily liquidity, transparency and security for directly purchasing bitcoin through a regulated ETF structure.”

In reaction to the news Sui Chung, CEO of CF Benchmarks said: "The cryptocurrency market becomes more integrated with the traditional financial markets by the day. Evolve has developed a true first - giving investors an easy-to-understand product that is available through their existing brokers and advisors that gives ownership of bitcoin. By tracking the Bitcoin Reference Rate from CF Benchmarks, the ETF tracks the value of bitcoin." Looking ahead, Chung also remarked: "Now that the OSC has said that if a product is well constructed enough, the crypto market is sufficiently mature for products that can be accessed by all investors, the industry's attention inevitably turns south of the border to the US. Will the SEC finally decide that the time is right for a Bitcoin ETF?"

CF Benchmarks Ltd Index Data is used under license as a source of information for certain Evolve Funds Group Inc. products. CF Benchmarks Ltd and its agents have no other connection to Evolve Funds Group Inc. products and services and do not sponsor, endorse, recommend or promote any Evolve Funds Group Inc. products or services. CF Benchmarks and its agents have no obligation or liability in connection with the Evolve Funds Group Inc. products and services. CF Benchmarks and its agents do not guarantee the accuracy and/or the completeness of any index licensed to Evolve Funds Group inc. and shall not have any liability for any errors, omissions, or interruptions therein.

Read Evolve Funds Group Inc.’s full announcement here.

Find out more about Bitcoin ETF here.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.

CF Benchmarks Ltd (“CF Benchmarks”), a company registered in England and Wales with company number 11654816 and authorised and regulated by the Financial Conduct Authority. Information about us can be found on the Financial Services Register (register number 847100).

Registered Office: 6th Floor One London Wall, London, United Kingdom, EC2Y 5EB.

You agree not to, and have no rights to, use the CF Benchmarks Data to create, calculate, issue, settle, maintain, support or develop any financial instruments (including but, without limitation exchange traded products, certificates, warrants, contracts for difference, swaps, binary options, structured products), indices, products, services (including but without limitation, portfolio management services, pre- and post-trade risk management services, or valuation services) or any other derivative works without the express written consent of CF Benchmarrks.

You agree not to analyze, reverse-engineer or disassemble any CF Benchmarks data and not to insert any code or product to manipulate the Website content in any way that affects any user’s experience. Unless CF Benchmarks gives you prior written permission, use of any Web browsers (other than generally available third-party browsers), engines, scripts, software, spiders, robots, avatars, agents, tools or other devices or mechanisms (such as crawlers, browser plug-ins and add-ons, or other technology) to navigate, access, copy in bulk, retrieve, harvest, index, search or analyse any portion of the Website is strictly prohibited.

No part of this information may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of CF Benchmarks Ltd. Use and distribution of the CF Benchmarks data requires a license from CF Benchmarks or its authorized licensing agents.

All information is provided for information purposes only. All information and data contained on this website is obtained by CF Benchmarks, from sources believed by it to be accurate and reliable. Such information and data is provided "as is" without warranty of any kind.

CF Benchmarks, nor its directors, officers, employees, partners or licensors make any claim, prediction, warranty or representation whatsoever, expressly or implied, either as to the accuracy, timeliness, completeness or merchantability of any information or of results to be obtained from the use of the CF Benchmarks indices or the fitness or suitability of the same indices for any particular purpose to which they might be put. Any representation of historical data accessible through CF Benchmarks indices is provided for information purposes only and is not a reliable indicator of future performance.

No responsibility or liability can be accepted by CF Benchmarks nor their respective directors, officers, employees, partners or licensors for any loss or damage in whole or in part caused by, resulting from, or relating to any error (negligent or otherwise) or other circumstance involved in procuring, collecting, compiling, interpreting, analysing, editing, transcribing, transmitting, communicating or delivering any such information or data or from use of this website or links to this website.

CF Benchmarks and its respective directors, officers, employees, partners or licensors do not provide investment advice and nothing accessible through CF Benchmarks, should be taken as constituting financial or investment advice or a financial promotion. Charts and graphs are provided for illustrative purposes only. Index returns shown may not represent the results of the actual trading of any assets.

CF Benchmarks is a member of the Crypto Facilities group of companies which is in turn a member of the Payward, Inc. group of companies. Payward, Inc. is the owner and operator of the Kraken Exchange, a venue that facilitates the trading of cryptocurrencies. The Kraken Exchange is a source of input data for certain CF Benchmarks indices. Payward, Inc. is the owner and operator of the Staked, a venue that operates the block production nodes for decentralized PoS protocols on behalf of institutional investors. Staked.us is a source of input data for certain CF Benchmarks indices.

Please refer to the individual product family documentation for more information about applicable input data sources.